Imagine using tiny, precise beams of light to find diseases inside the body or in a lab sample. Usually, turning these lab discoveries into real medical products takes years because the manufacturing is too complex. This project creates a shared 'fast track' production line that helps companies build and test these light-based tools much quicker.
The transition from a lab-proven photonic concept to a regulated medical product takes years and costs millions due to fragmented supply chains. Companies struggle to find scalable manufacturing for specialized light-based components.
A pilot line infrastructure including CMOS-compatible plasmonic waveguides, hybrid lasers, and miniaturized opto-fluidic integration modules.
If you are a diagnostic kit manufacturer dealing with slow development cycles for biosensors — this project developed CMOS-compatible plasmonic waveguides that enable scalable biosensing. This reduces the time it takes to move from a lab concept to a commercial product.
If you are a device developer dealing with the bulkiness of current sensors — this project developed optimized SOI and SiN waveguides for integration into wearable devices. This allows for more compact and clinically relevant device architectures.
If you are a tool provider dealing with the difficulty of integrating lasers into small probes — this project developed hybrid InP/Si and GaSb/SiN/SOI lasers. These provide tunable and mid-infrared sources for high-precision internal diagnostics.
Based on available project data, it reduces costs by using a pilot line operational model and defined industrial supply chains, which substantially shortens the time-to-market.
Yes, the project focuses on CMOS-compatible fabrication and high fabrication yields to ensure that the photonic components are scalable for mass production.
Based on available project data, technologies developed will be appended to the pilot line offering, making them available to companies outside the original project consortium.
The project runs from 2024-09-01 to 2027-08-31, focusing on accelerating the uptake of technologies through 16 specific pilot cases.
The project developed opto-fluidic systems, fiber-optic interfaces, and miniaturized photonic modules to support compact and scalable device architectures.
The consortium is heavily industry-driven, with 27 industrial partners (69% of the total) and 24 SMEs. This high concentration of commercial players, alongside 5 universities and 5 research organizations across 9 countries, indicates a strong focus on commercial viability and market integration rather than pure academic research.
Contact TEKNOLOGIAN TUTKIMUSKESKUS VTT OY in Finland
Contact us to identify which of the 16 pilot-case technologies fit your product roadmap.
